Heart and bile acids – Clinical consequences of altered bile acid metabolism

• Published in: Biochimica et Biophysica Acta - Molecular Basis of Disease
• Main Author: Vasavan T.; Ferraro E.; Ibrahim E.; Dixon P.; Gorelik J.; Williamson C.
• Format: Review
• Language: English
• Published: Elsevier B.V. 2018
• Online Access: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85040575162&doi=10.1016%2fj.bbadis.2017.12.039&partnerID=40&md5=7373cc0cd4ed370425e2e62c6148a4ce

Cardiac dysfunction has an increased prevalence in diseases complicated by liver cirrhosis such as primary biliary cholangitis and primary sclerosing cholangitis. This observation has led to research into the association between abnormalities in bile acid metabolism and cardiac pathology. Approximately 50% of liver cirrhosis cases develop cirrhotic cardiomyopathy. Bile acids are directly implicated in this, causing QT interval prolongation, cardiac hypertrophy, cardiomyocyte apoptosis and abnormal haemodynamics of the heart. Elevated maternal serum bile acids in intrahepatic cholestasis of pregnancy, a disorder which causes an impaired feto-maternal bile acid gradient, have been associated with fatal fetal arrhythmias. The hydrophobicity of individual bile acids in the serum bile acid pool is of relevance, with relatively lipophilic bile acids having a more harmful effect on the heart. Ursodeoxycholic acid can reverse or protect against these detrimental cardiac effects of elevated bile acids. © 2018 Elsevier B.V.